On May, 31 Analysts See $0.60 EPS for Cantel Medical Corp. (CMD)

May 16, 2018 - By Karla Blount

Cantel Medical Corp. (NYSE:CMD)’s earnings report is awaited by WallStreet on May, 31, Zacks reports. Analysts forecast $0.60 EPS, which is $0.09 up or 17.65 % from 2017’s $0.51 EPS. CMD’s profit could reach $25.03M with 53.12 P/E in case $0.60 EPS is reported. Wall Street predicts 1.69 % EPS growth as of May, 31. CMD is touching $127.48 during the last trading session, after increased 2.07%.Cantel Medical Corp. has volume of 217,886 shares. Since May 17, 2017 CMD has risen 41.41% and is uptrending. The stock outperformed the S&P500 by 29.86%.

Cantel Medical Corp. provides infection prevention services and products for the healthcare market worldwide.The company has $5.32 billion market cap. The firm operates through four divisions: Endoscopy, Water Purification and Filtration, Healthcare Disposables, and Dialysis.59.13 is the P/E ratio. The Endoscopy segment offers automated endoscope reprocessing systems; detergents; leak testing and manual cleaning products; storage cabinets; transport systems; mobile medical carts; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid and flexible endoscopes, and other instrumentation; cleaning and disinfecting reusable components used in gastrointestinal endoscopy procedures; and technical maintenance services.

There’s a significant Cantel Medical Corp. (NYSE:CMD) news brought out by Benzinga.com. It’s a report titled: “Jim Cramer Weighs In On Align Technology, Berkshire Hathaway, Symantec And More” on May 15, 2018.

Cantel Medical Corp. (NYSE:CMD) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: